Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma

Clinical trial NCT04200326 · COMPLETED

Trial details

NCT number: NCT04200326
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Severe Uncontrolled Asthma

Start date: 2019-12-20
Primary completion: 2020-04-09
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.